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How might improved estimates of HIV
programme outcomes influence practice? A
formative study of evidence, dissemination
and response
Njekwa Mukamba1* , Laura K. Beres2, Chanda Mwamba1, Jeanna Wallenta Law3, Stephanie M. Topp4,
Sandra Simbeza1, Kombatende Sikombe1, Nancy Padian5, Charles B. Holmes6,7, Elvin H. Geng8 and
Izukanji Sikazwe1

Abstract
Background: While HIV programmes have started millions of persons on life-saving antiretroviral therapy in Africa,
longitudinal health information systems are frail and, therefore, data about long-term survival is often inaccurate or
unknown to HIV programmes. The ‘Better Information for Health in Zambia’ (BetterInfo) Study – a regional
sampling-based survey to assess retention and mortality in HIV programmes in Zambia – found both retention and
mortality to be higher than prevailing estimates from national surveillance systems. We sought to understand how
Zambian health decision-makers at different health system levels would respond to these new data, with a view to
informing research translation.
Methods: We interviewed 25 purposefully sampled health decision-makers from community, facility, district,
provincial and national levels. During the interviews, we shared retention and mortality estimates from both routine
programme surveillance and those generated by the study. Transcripts were analysed for inductive and deductive
themes, the latter drawing on Weiss’s framework that policy-makers interpret and apply evidence as ‘warning’,
‘guidance’, ‘reconceptualisation’ or ‘mobilisation of support’.
Findings: All decision-makers found study findings relevant and important. Decision-makers viewed the
underestimates of mortality to be a warning about the veracity and informativeness of routine data systems.
Decision-makers felt guided by the findings to improve data monitoring and, acknowledging limitations of routine
data, utilised episodic patient tracing to support improved data accuracy. Findings catalysed renewed motivation
and mobilisation by national level decision-makers for differentiated models of HIV care to improve patient
outcomes and also improved data management systems to better capture patient outcomes. Inductive analysis
highlighted a programmatic application data interpretation, in which study findings can influence facility and
patient-level decision-making, quality of care and routine data management.
(Continued on next page)
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(Continued from previous page)

Conclusions: New epidemiological data on patient outcomes were widely seen as informative and relevant and
can potentially catalyse health system action such as using evaluations to supplement electronic medical record
data to improve HIV programmes. Formative evidence suggests that targeting research dissemination at different
levels of the health system will elicit different responses. Researchers supporting the translation of evidence to
action should leverage all relevant levels of the health system to facilitate both policy and programmatic action.
Keywords: HIV outcomes, dissemination, health decision-making, implementation science

Introduction
Researchers often assume that better data from health
programmes will lead to better policy and implementation of these health programmes but the effects of
data on the policy-making environment for HIV treatment in Africa may have a range of both intended
and unintended effects. Indeed, implementation research as well as allied movements in evidence-based
medicine and evidence-based public health view improved health outcomes as a result of the translation
of research findings to advance policy and practice
[1]. Yet, the policy-making environment is a complex
ecosystem of actors, sometimes with different and
perhaps hidden agendas. The effects of more accurate
information about outcomes on this environment in
HIV programmes in the global south is not well
characterised.
Most effective approaches to facilitate evidence translation addressing these complex dynamics remain
unclear, especially in the environment of the global HIV
response [2]. Further, contextualising research evidence
for more effective policy-making and practice remains a
major challenge [1]. HIV care and treatment
programmes are at a critical juncture, particularly in
sub-Saharan Africa, as they transition from an
emergency-based response to chronic disease management. Long-term and sustained beneficial health outcomes in both treatment and prevention require health
decision-makers to have accurate HIV patient retention
and outcome data upon which to base programme and
policy decisions. However, health information systems
are weak in many low- and middle-income countries [2],
resulting in poor local and national-level patient vital
status and care engagement data. As efforts to supplement routine health information with improved data
become available, more information is needed to understand how health decision-makers may take up and
apply new evidence in the HIV response [3]. Making decisions on the basis of the best-available scientific
evidence, using data and information systems systematically, applying programme-planning frameworks, engaging the community in decision-making, conducting
sound evaluation, and disseminating what is learned at

different health system levels are key in the context of
evidence-based public health [4].
Studies suggest that the relationship between the research that generates evidence and knowledge translation is complex, with varied factors operating at the
individual, organisational, systems and contextual levels
[1]. A study on maternal health decision-making in
Ghana highlights that two key factors commonly identified as enhancing the use of research were the relevance
of the topic and the speed with which findings were
generated [5]. Additional factors identified in a study on
research influence in policy-making for eclampsia treatment and malaria control across three Southern African
countries (Mozambique, South Africa and Zimbabwe)
included the backgrounds and experience of policymakers and researchers, cultures of evidence use and
broader national political (e.g. elections, policy windows)
and bureaucratic (e.g. drug procurement and distribution) processes [6]. Another important factor was the
role of policy networks beyond the national setting as a
conduit for transferring research findings into policy [6].
However, some of the factors that may affect the use of
research evidence include its perceived importance, access to latest research and methods of collection, and inadequate human resources to deliver an evidence-based
intervention, among others reasons [7].
While there are examples where HIV/AIDS research
has influenced policy, it is well documented that research that rigorously demonstrates beneficial interventions does not necessarily lead to policy change [3]. Few
studies have examined the translation of HIV research
findings that improve routine data systems.
In this research study, we utilised key informant
interviews (KIIs) to understand how Zambian health
decision-makers at different levels of the health system
would perceive and respond to more accurate mortality
and retention estimates than routine HIV programme
data can currently provide and to learn their perspectives on how the data could be used to improve the HIV
response following the dissemination of study findings.
To the best of our knowledge, this is the first study that
highlights how health decision-makers at different levels
of the Zambian health system understand and respond
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to improved HIV retention and mortality estimates and
the associated drivers of disengagement from HIV care.
This study offers the unique perspective on how
decision-makers may respond to data that are new
though directly related to programmatic data as opposed
to more traditional stand-alone research. In this paper,
we provide insights on the perceived value and response
to the revised retention and mortality estimates in HIV
care and treatment programmes in Zambia.
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Table 1 Number of key informant interview participants by sex,
decision-making level and province
Characteristics

No. of participants

Total

25

Gender
Male

15

Female

10

Level of decision-making
National

4

Methods

Provincial

3

Study background

District

3

Facility

12

Community

3

This qualitative study was nested within a larger quantitative study entitled, Better Information for Health in
Zambia (BetterInfo). BetterInfo determined provincially
valid, revised estimates of HIV programme mortality and
retention by identifying the outcomes (alive or deceased;
engaged or not engaged in care) of patients lost to
follow-up (LTFU) and identified the reasons for disengagement from HIV care in 32 public health facilities
across four Zambian provinces – Eastern, Lusaka, Southern and Western. The data on patient visits, LTFU status, socio-demographic and clinical characteristics were
obtained from the national Zambian Electronic Medical
Records (EMR) system. Tracing of patients that were
LTFU for outcomes determination was done by review
of patients’ paper records, phone communication or inperson visits within the community by recruited research
assistants with experience in HIV counselling, tracing of
LTFU and good knowledge of surrounding communities.
Patients that were LTFU were traced between October
2015 and June 2016. In terms of collecting outcome
data, patients were categorised as having died if review
of EMR, paper records or the tracing process found evidence that the patient was deceased. Patients were categorised as being alive if communicated to in-person or
an informant was contacted and confirmed knowing the
patient [8, 9].
Study population and sampling

We purposefully sampled health decision-makers from
the four study provinces across the national, provincial,
district, facility and community levels of the health system associated with the 32 facilities that had BetterInfo
revised outcome estimates (Table 1) [10, 11]. National
health decision-makers were selected to represent Ministry of Health headquarters and cooperating partners
whose role is health policy formulation and regulation.
Provincial Health Office participants were selected to
represent an administrative link between the national
and district level in healthcare delivery. District Health
Office participants represent those offering technical
support in provision of health services and hospital management. Health facility-level decision-makers included

Province
Lusaka

7

Southern

6

Eastern

6

Western

6

facility and antiretroviral therapy (ART) department InCharges. The role of In-Charges is to manage the public
health facility and involve community structures in
health matters. The community decision-makers represented executive members of the Neighbourhood Health
Committees (NHCs), who participate in health matters
and perform non-specialised tasks delegated by healthcare workers (HCWs). More specifically, the role of
NHCs is to identify health needs in the community, collect community evidence, plan and work with health
centres on shared concerns [12].
Study procedures and data collection

Data collection was conducted between July and
September 2016. KIIs were conducted by a team of two
to three researchers per interview in English using a
semi-structured guide. Prior to study implementation,
the researchers, trained in qualitative methods, underwent training in order to gain familiarity with the study’s
aims and with the interview guide [13, 14]. During this
qualitative study, the researchers first described the BetterInfo study methods (Box 1) and then presented the
original patient outcome estimates from the routine
Zambian National HIV Electronic Medical Record or
‘Smart Care’ data alongside the more accurate BetterInfo
study estimates of retention and mortality (Fig. 1, example data as shown to health decision-makers).
The data was presented in hard copy format during the
interviews, which were conducted in Eastern, Lusaka,
Southern and Western Provinces. The presented data
were disaggregated by the level at which the health
decision-maker operated (i.e. community, facility, district,
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Fig. 1 Example of routine health system ‘naïve’ electronic medical record system estimates versus revised estimates in new antiretroviral therapy
initiators from the Better Information for Health in Zambia (2016) study: preliminary study findings

provincial or national). Therefore, national level health
decision-makers were presented with data across the four
provinces while, at province, district, facility and community level, it was only data specific to their health decisionmaking level that was presented.
While there was variation by facility, the BetterInfo
study demonstrated that there was a marked underestimation of both HIV patient retention and mortality by the routine EMR system among new ART
initiators [8, 9]. In addition, the researchers presented drivers of patient disengagement from HIV
care as determined during BetterInfo study interviews
and focus group discussions with patients and HCWs
[14, 15] (Box 2).
We then used open-ended questions and probes to ask
the participants what they thought of the HIV mortality
and retention estimates and the drivers of disengagement from HIV care after each set of results was shared.
We also covered topics including frequency of collecting
revised estimates, key challenges and priorities to improve HIV care and treatment, the likelihood of health
decision-makers implementing HIV programme changes
as a result of the BetterInfo revised estimates, and perceived influence on strengthening HIV care and treatment programmes.
Data analysis

The interviews were audio-recorded, transcribed verbatim and transcripts were uploaded to QSR™ Nvivo for
analysis. In instances where the participant refused
audio-recording (n = 1), notes taken during the interview
were analysed. Analysis included repeat reading of the
transcripts by three researchers [16–18], discussion of
inductive and deductive themes to create a code book,
and application of the codes to the full dataset by the
three researchers [19]. Deductive coding was guided by
Weiss’s framework, which postulates that policy-makers

utilise evaluation information for ‘warning’, ‘guidance’,
‘reconceptualisation’ or ‘mobilisation of support’ [20].
Concept maps were then used to categorise and conceptualise results [21]. Differences in interpretation were
resolved through dialogue among the researchers.
Researchers conducted reflexivity exercises prior to the
data collection and during analysis to identify their own
positionality and improve their self-awareness [22, 23].
Conceptual framework

Analysis was guided by the Weiss framework, which
hypothesises that policy-makers or actors take-in
research findings as ‘warning’, ‘guidance’, opportunities
for ‘reconceptualisation’ or ‘mobilisation of support’
(Fig. 2) [20].
When evidenced-based information shows that programmatic outcomes are not meeting targets, then it is
serving as ‘warning’ and this may prompt policy response.
Evidenced-based information serves as ‘guidance’ when it
is providing direction for improving policies and programmes. This may result in giving suggestions of what
works well under the prevailing conditions. However, the
influence of evidenced-based information is likely to be
much more on new programmes and policies as compared to existent ones. Evidenced-based information
serves as ‘reconceptualisation’ when they provide new
ways of thinking to familiar issues and help policy-makers
to reinterpret events, consider the past and assess the reasons for success. Additionally, evidenced-based information can be used to ‘mobilise support for programme or
policy proposals’, especially as a means of persuading and
convincing those who may be undecided.
Ethical approval and consent to participate

Participants provided written informed consent for participation. Ethical approval was granted by the University
of Zambia Biomedical Research Ethics Committee, the
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Fig. 2 Schematic figure depicting the Weiss framework on uses of evidenced-based information [20]

University of Alabama at Birmingham and the Zambian
Ministry of Health.

Results
We conducted a total of 25 KIIs across the different
health decision-making levels and provinces (Table 1).
Among participants who communicated their length of
HIV service in the health profession (56% of sample),
participants reported between 2 and over 10 years of
experience, with most having more than 5 years.
The Zambian health decision-makers at all levels
found the improved HIV retention and mortality estimates and reasons for disengagement from HIV care to
be important and compelling for the HIV programme in
Zambia. In expressing approval for improved HIV
mortality estimates, a participant stated:
“I think I would agree with what was found on the
estimates especially on mortality. I would agree with
the study because low mortality rate in the EMR
system is in reference to the reported deaths without
considering the LTFU.” (Facility Level)
Another participant regarded the patient-reported reasons for disengagement from HIV care to be genuine:
“These findings to us are very helpful because
sometimes we take things for granted and we behave in the usual way. Yes – the reasons why patients disengage from HIV care seem to be real.”
(District Level)
Health decision-makers’ responses to our dissemination
of the revised HIV programme outcome estimates were
consistent with the Weiss framework in that health

decision-makers interpret new research data in one of
four ways: ‘warning’, ‘mobilising support’, ‘reconceptualising’ and ‘guidance’. Inductive analysis highlighted
another key response, which we called ‘programmatic
application’ of the findings. Often, health decisionmakers responded in multiple categories of the Weiss
framework. For instance, one participant felt both
‘warned’ about inaccuracies of EMR and simultaneously
‘guided’ to improve data accuracy.
Warning

Interpretation of improved estimates as a ‘warning’
meant that the health decision-makers received the new
information as an indication of a problem of which they
were unaware or which they had not previously viewed
as pressing. Unlike those at community level, health
decision-makers across the national, provincial, district
and facility health system levels felt warned about higher
than expected HIV mortality estimates and inaccuracies
of the EMR.
High HIV mortality estimates

Study data demonstrating that routine EMRs underestimated mortality alerted health decision-makers, especially at provincial, district and facility levels, that
mortality was a more frequent outcome that was previously understood. A participant stated:
“I am concerned and surprised to learn that we have a
lot of alive patients who are out of HIV care, meaning
they are not being care for. And at the same time, the
level of HIV mortality is too high.” (Provincial Level)
Reflecting on the surprising data, another participant offered an explanation that the high HIV mortality
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estimates found by the study may be because of underreporting of deaths that occur at community level:
“One of the reasons of understating mortality rate in
EMR is that relatives hardly get back to the hospital
or health facility to report any HIV-related death
and this is the reason they are considered lost even
when they are actually dead.” (Facility Level)
During the interviews, participants who felt warned
offered explanations for the presented data:
“I will say EMR in terms of data accuracy I think it’s
very very questionable. At any particular time you
look, it doesn’t reflect what is exactly happening at
that time.” (Provincial Level)

Inaccuracies in EMR

Seeing the differences between what the study found by
incorporating the findings from outcomes of patients
that were LTFU and the routine EMR alerted decisionmakers to routine programme inaccuracies. The revised
estimates explicitly demonstrated that the EMR outcomes included ‘unknown’ outcomes making it difficult
to understand programme-level effectiveness. One participant said:
“This is worrisome because we have this number of
people who are unattended. It means that as a
province and together with our partners these are the
issues which we need to devise interventions for.” (Provincial Level)

Mobilisation of support

Most participants interpreted the study findings as demonstrating a need for ‘mobilisation of support’ for a policy or practice change that they already favoured. A
‘mobilisation of support’ interpretation was especially
common to provincial, national, district and facility level
participants. Additionally, all provinces related to the
reasons for patient disengagement, including the challenging health systems factors and the idea that HIV
treatment access interferes with a patient’s role in their
family. Participants often responded by raising key
health systems issues they had already believed were important and which they thought were consistent with
the evidence presented such as the attitude and availability of HCWs. Health decision-makers connected the
evidence presented with systems changes, including
strategies like differentiated service delivery (DSD)
models to improve HIV care access and quality and
needed improvements to the routine EMR.
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HIV care and treatment access and quality

Many health decision-makers interpreted the reported
reasons for patient disengagement as indicative of a need
to facilitate access to ART outside of the facility such as
in community-settings. Participants from national, provincial and district health system levels highlighted the
need for DSD models that could reduce the distance
travelled and time-spent accessing healthcare:
“I think the buzz word now is providing DSD models
of HIV care that are patient-based and enable patients to receive their medication within the community level.” (National Level)
In response to the reported reasons for disengagement,
health decision-makers also highlighted the on-going
need for increased staffing at health facilities:
“We need more man-power at ART so that clients
are seen there and then instead of waiting for too
long.” (Facility Level)
Other health system changes advocated for by participants included instituting appointment systems in the
facilities, the use of unique patient identifiers and enhancing tracking of patients that were LTFU through
community-based volunteers.
In response to reported barriers to engagement, such
as HCW attitudes, health decision-makers generally accepted this as a challenge, especially at district level, and
used the finding to underline a felt need for improved
patient–provider interactions:
“We need to talk with our staff about their attitude. I
think this is something that can easily be done in the
way they need to handle these patients.” (District Level)
Improved accuracy of EMR system

Health decision-makers at national, provincial, district
and facility levels also interpreted the improved estimates as concrete evidence supporting their current
awareness of the limitations of the routine EMR. In response to the improved estimates, participants, especially
at district and facility level, discussed a need to ensure
timely entry of data and to have sufficient human resources for data management. The health decisionmakers discussed that these measures would reduce the
backlog of data entry that leads to inaccurate data.
“Many people who are still in the HIV care
programme are recorded as lost to follow-up, it tells
us that we really need to do a lot for our own information. I think the major problem is that, in the past, we
used to have data entry clerks, and these were phased
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out. Sometimes, we rely on our health facility staff
who are busy to enter patients’ files properly and that
is where this problem comes in.” (District Level)
Reconceptualisation

Reconceptualisation related to health decision-makers
interpreting the study findings as offering new ways of
thinking or re-interpreting what happened in the past
with respect to HIV care and treatment. Perhaps the
most prominent example in this domain was of
decision-makers using the improved estimates to reconceptualise LTFU as not only a problem but also as representing patients with specific outcomes – deaths, in-care
but undocumented or disengaged. Interviews showed
that many participants either assumed that patients that
were LTFU were disengaged or did not consider these
patient outcomes in relation to programme performance.
Discussion around the implications of the underestimation of HIV retention in EMR were prominent
themes in interviews with national, provincial and facility
level health decision-makers.
“What has surprised me is that a lot of people whom
we thought were actually lost-to-follow- up they are
actually in care somewhere.” (Facility Level)
One conclusion shared from reconceptualisation was
that the revised estimates could motivate HCWs in their
work. A participant stated:
“The revised retention estimates is motivating to
HCWs. We look for ways to motivate our HCWs and
here it is. What an encouragement it is for people to
realise that retention in HIV care is higher than
what Smart Care shows. This is the source of motivation. HCWs need to be a lot more accurate in collecting data as lost patients are actually active
somewhere in HIV care.” (National Level)
Particularly for facility and district-level health
decision-makers, the improved estimates also led to
reconceptualisation of LTFU as contributing to higher
mortality:
“It’s quite enlightening to pick up this information
showing that we have much more in terms of mortality than we assumed.” (Facility Level)
Community-level participants did not respond to the revised mortality estimates in the same way. They were
more likely to reflect an existing awareness that HIVrelated deaths occurring in the community are rarely
communicated to the health facilities and that the EMR
fails to capture all deaths.
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Guidance

Guidance related to health decision-makers’ reaction to
study findings by suggesting what would work better in
HIV care and treatment programmes as a result of being
influenced by the study findings rather than preconceived ideas. In response to the revised estimates, health
decision-makers were guided to improve the tracking of
patients that were LTFU and the accuracy of EMR.
Improved tracking of patients that were LTFU

When presented with the improved estimates and the
information that they were obtained through in-person
follow-up of a sample of patients that were LTFU, health
decision-makers discussed the need to track these patients so that their true health outcomes can become
known. This was particularly prominent among participants at the community, health facility and provincial
levels.
“Something needs to be done to locate those people
with unknown outcomes. That’s where even the
Neighbourhood Health Committees should be involved in locating these people.” (Community Level)
Expounding upon the value that tracking could add, it
was recommended by community-level decision-makers
that involving people who are well-known within the
community and especially the NHCs would help to effectively track patients that were LTFU.
Improved data accuracy in EMR

Accuracy in data management in EMR was highlighted
in the context of how the improved HIV mortality and
retention estimates would change the implementation of
HIV care and treatment at the different health system
levels. National, provincial and, especially, facility-level
health decision-makers were guided to be more accurate
in the management and tallying of patient data, as stated
below:
“Just to understand that you don’t need to beat
yourselves too hard, you just need to be a lot more
accurate in the way you collect data, these patients you
have lost are actually active in care elsewhere.”
(National Level)
In order to achieve data accuracy and quality, many
facility-level health decision-makers were of the view
that EMR data needs to be regularly monitored and updated, as expressed below.
“I think we need to monitor the data at each and
every stage so that the data we produce should be of
more quality than just quantity.” (Facility Level)
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Programmatic application

In addition to the four categories from Weiss’ framework,
inductive analysis revealed another key response related
to how study findings may be used to strengthen HIV care
and treatment programmes. We called this theme ‘programmatic application’, which most often came as a direct
response to an interview question asking participants to
reflect on how they thought the study findings shared
may influence their practice. All health decision-makers
across the different levels pointed out two direct actions
that the study findings may be applied to – (1) improved
quality care and (2) planning and decision-making.
Improved quality care

When asked about the likelihood of the improved study
estimates influencing changes about the implementation
of HIV care and treatment, health decision-makers,
mostly at facility, district and provincial levels, suggested
health system actions aimed at improving the quality of
care in order to minimise disengagement from HIV care,
such as positive HCW attitudes, improved staffing levels
and appointment systems, which could result in improved patient wellbeing and reduce LTFU.
“At district level, we need to talk with our staff about
their attitude. I think this is something that can easily be done to remind them of the way they need to
handle these patients. And in view of under-staffing
levels, waiting time can be reduced by properly
scheduled appointments.” (District Level)
Planning and decision-making

In response to a question of how health decision-makers
would make use of the improved study estimates, community, facility, district, provincial and national health
decision-makers suggested that the improved study estimates are useful for planning and making decisions on
LTFU activities at different levels of the health system. The
use of improved study estimates for planning purposes was
prominent among facility level health decision-makers.
“The revised estimates by BetterInfo study has given
us a picture of how we are performing as a facility.
These negative findings that have been brought to us
would really help us in planning and monitoring our
activities of following or tracing LTFU and also request for qualified health staff.” (Facility Level)

Discussion
Our findings demonstrate that many health decisionmakers were generally unaware of the extent of inaccuracies of the routine, programmatic EMR system. However,
many of the identified drivers of patient disengagement
from HIV care were well recognised and accepted as
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health system challenges. Importantly, our findings highlight that decision-makers at different levels of the health
system respond in different ways, with national-level participants suggesting more structural responses, such as
improved data management and use of DSDs, while lower
levels of the health system more commonly addressed patient–provider interaction and quality of care-related initiatives. Future researchers may improve the speed of
evidence uptake and breadth of data use by engaging with
different levels of the health system.
Health decision-makers in HIV programmes integrated the new information and rapidly provided meaningful and actionable explanations for evaluation data,
which may reflect an initial suspicion of some degree of
inaccuracy in the EMR among many participants. The
dissemination of study findings, which revealed that patients labelled ‘LTFU’ are often either still in care, or,
conversely, deceased, led participants to feel warned by
the extent and nature of EMR limitations and to reconceptualise the label of ‘LTFU’ as a gap in HIV patient
outcome information. Health decision-makers at different health system levels, including those who had previously reflected on the problem of LTFU and those for
whom the revised estimates felt like new information, offered both further insights and possible explanations for
the revised HIV mortality and retention estimates during
the interviews. Studies should use early dissemination to
inform their research to policy recommendations, working with health decision-makers to generate ideas about
future interventions meant to address identified gaps in
HIV programmes. This is consistent with a study from
Nigeria, which underscores that timeliness and relevance
of research results are among best practices in promoting the application of research results [24]. While our research stops short of observing actions taken based on
findings, many of the decision-makers interviewed proposed actionable responses consistent with the Weiss
framework [20] such as being ‘warned’ about inaccuracies of EMR, being ‘guided’ to improve data accuracy
and ‘mobilising support’ for DSD models to improve access and quality of HIV care. Our research offers evidence of Weiss’ optimistic conceptualisation of data and
evaluation as providing steps to more ‘enlightened’
policy-making, and that there is a complex path between
evidence-based information and policy. Similarly, increased awareness of the problem of incomplete programmatic data and strategies, such as periodic
research-based approaches to filling gaps, could contribute to advancing the problem and policy streams that
could lead to future change [25]. While a dedicated effort was necessary and feasible to obtain these data [8,
9], utilising a sampling-based approach can allow other
health programmes to obtain similar estimates to inform
decision-making.
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Our formative evidence suggests that targeting research
dissemination at different levels of the health system elicits
different responses. We found variation in the themes
present in responses across different levels of the health
system. National, provincial and facility-level health
decision-makers were more often warned about higher
than expected HIV mortality estimates and inaccuracies of
EMR. Our study confirmed that HCW perceptions of HIV
retention and mortality are not an accurate reflection of
the HIV programme. However, community-level health
decision-makers seemed more aware of unrecorded HIV
mortality and were of the view that HIV-related deaths
that happen at community level were often not reported
to health facilities, thereby contributing to gaps in EMR
[9]. Community-level decision-makers mobilised support
for facility level initiatives such as effective tracking of patients that were LTFU using NHCs in order to establish
their true health outcomes. Tracking of patients that were
LTFU by community health workers is key in fostering reengagement in HIV care as shown by a research study
conducted in sub-Saharan Africa [26]. Given the diversity
of responses at different health levels, research dissemination should target the different health system levels because the audience and users of research findings are
likely to have varied needs and application of research evidence [27]. Additionally, our study shows empirical evidence that different actors in the health systems have
different responses and priorities. While better data speak
to each level of decision-maker, it does so in different
ways and, consequently, there is no one ‘evidence-based
policy’. Therefore, researchers should also be clear on who
the target audience for dissemination is and what health
system level they operate, so that dissemination messages
are tailored towards their objectives and needs. This is
consistent with findings from other settings [28]. This targeting is critical for informing the next steps in utilising
and disseminating the revised estimates of patient outcomes in order to facilitate health system improvement.
Our findings highlight an opportunity suggested by
several participants that new epidemiological data on patient outcomes may motivate HCWs in providing quality
HIV services. Consistent with other research, participants suggested that the positive findings of increased
retention in care would motivate HCWs in their jobs
[29]. Primarily, provincial and national health decisionmakers were aware of LTFU as a challenge but demonstrated a reconceptualisation response in the interviews,
expressing that more detailed information on the
outcomes of patients, including a higher proportion of
patients with undocumented retention in care, could be
motivating to HCWs. These key decision-makers interpreted that higher HIV retention estimates not only
serve as an encouragement for HCWs to provide quality
health services but also underscores the overall success

of the HIV programme, while still needing to address
higher mortality than previously estimated.
Zambian decision-makers’ perceptions and experiences
regarding the drivers of patient disengagement were found
to strongly align with the BetterInfo qualitative study findings presented to them. There was concurrence with both
the patient-level social factors identified and the health
systems challenges. Considering these barriers, decisionmakers proposed improving the quality of care as a strategy intended to enhance HIV retention. This is consistent
with current literature that improving the patient experience at health facility level has the potential to reduce
LTFU and increase retention in HIV care [30]. For instance, health decision-makers at the facility, district and
provincial levels suggested health system actions aimed at
improving the quality of HIV care to better the patient experience by supporting positive HCW attitudes, staffing
levels and appointment systems. It is important for HIV
programmes to make use of evidenced-based research as
it provides a good basis for meaningful engagement with
health decision-makers at different levels and the feedback
obtained can be used to validate the findings and advocate
strategies aimed at enhancing HIV retention.
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Study limitations

This study was formative in nature. While gathering data
for use is key, we cannot infer data use beyond the initial
responses from the decision-makers. However, the research was intended to understand how health outcomes
information that improves upon routine programmatic
data can be better positioned for translation by highlighting important decision-maker concerns and priorities.
Our findings were not intended for generalisability. However, they may be applicable in transferable settings [31],
including health systems and HIV contexts similar to
those in Zambia.

Conclusion
Our formative evidence suggests that targeting research
dissemination at different levels of the health system will
elicit different responses. Researchers supporting the
translation of empirical data to action should leverage all
relevant levels of the health system to facilitate both policy and programmatic action. Since the health decisionmaking levels are diverse, it is necessary that evaluation
data should be packaged and disseminated in a simple,
user-friendly but informative manner for health
decision-makers to understand the data. Future research
is needed to understand the actions or decisions taken
by the Zambian health decision-makers to improve HIV
care and treatment based on the disseminated evidence
and the effect of the actions suggested by the decisionmakers during the interviews.
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Box 1 Framing of BetterInfo Study Results
The following background and methods information was shared with
study participants:
The BetterInfo study traced a random sample of patients from 32 public
health facilities across 4 provinces – Southern, Eastern, Western and
Lusaka – who were lost to follow-up from those facilities. This was done
in order to find out what really happened to them and why. Patients
who are lost to follow-up are patients who had not returned to their
health facility for HIV care for 90 days (~3 months) after they missed their
last scheduled appointment or 180 days (~6 months) from any appointment. Trained patient tracers found out if the patients who were lost to
follow-up were still in HIV care or transferred to another health facility,
stopped HIV care, or had died. The patients were traced between October 2015 and June 2016.
Before this study, the routine health system or electronic medical
records (SmartCare) showed that the proportion of patients who died at
clinic/district/provincial/ was XX% and the proportion of patients who
had stopped HIV care was XX% and those accessing HIV care were XX%.
However, the BetterInfo study estimated these to be YY%, YY% and
YY%.

Box 2 Drivers of patient disengagement from HIV care
[14, 15]
This data was collected using in-depth interviews with patients and their
family members and focus group discussions with healthcare workers.
The two most important findings were as follows:
1. Engagement and disengagement from care is strongly
influenced by patients’ perception of their social identity and
social role. Example of social identities/roles are Mother, Father,
Breadwinner, Friend
• If patients perceived HIV care to negatively influence or interfere with
their social identity or social role (e.g. as a productive member of their
family), they were more likely to disengage from care. Two of the most
important factors that made people feel a negative impact of care
were (1) ongoing community-based stigma and (2) internalised stigma,
i.e. feeling ashamed.
• On the other hand, if patients perceived HIV care to strengthen their
social role (e.g. as a productive working family member) they were
more likely to engage and stay engaged.
2. Health system factors also had an important impact on
engagement and disengagement from care. These factors included:
• ‘Structural factors’ like distance to clinic, health worker availability and
wait times, which influenced whether patients could access care or
not.
• ‘Behavioural factors’ such as health worker attitudes and patients’
perceptions about healthcare workers’ respect. These factors influenced
how patients felt when they did access care.
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• Patients were more likely to be engaged if care was more accessible
and they felt positive when accessing it.
There is no single factor or set of factors that is responsible for
engagement or disengagement from HIV care. The factors play different
roles for different patients. Therefore, different individual, social and
health system factors interact to drive engagement and disengagement
from HIV care.
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